RSS2.0

Additional EU Approval for Lundbeck Psychosis Drug

Friday, January 12, 2007

Danish company Lundbeck has reported the approval of Cipralex in the EU for the treatment of obsessive compulsive disorder.
From: www.redorbit.com

0 comments: